ANTI-EMETIC EFFECTS IN PATIENTS RECEIVING CARBOPLATIN-PACLITAXEL WITH OR WITHOUT BEVACIZUMAB CATEGORIZED AS MODERATELY EMETOGENIC CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCERH. Watanabe, I. Hoshi, Y. Nakai, T. YanaANNALS OF ONCOLOGY（2012）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
